Cipla USA, Inc. recalls Diclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), Manufactured by: DPT Laboratories, Ltd., 307 E Josephine Str…
- Recall date
- December 22, 2025
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0291-2026
- FDA classification
- Class III
- Brand / firm
- Cipla USA, Inc.
- Sold / distributed
- Nationwide in the USA
Why it was recalled
Failed PH Specifications
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Diclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), Manufactured by: DPT Laboratories, Ltd., 307 E Josephine Street, San Antonio, TX 78215. NDC: 76282-103-39
Get recall alerts
Free email alert whenever Cipla USA, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Cipla USA, Inc.